{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:07:56Z","timestamp":1777615676875,"version":"3.51.4"},"reference-count":168,"publisher":"Elsevier","isbn-type":[{"value":"9780444641670","type":"print"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1016\/bs.pbr.2018.07.003","type":"book-chapter","created":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T00:07:19Z","timestamp":1537056439000},"page":"49-87","source":"Crossref","is-referenced-by-count":7,"title":["Modulation of the central opioid system as an antidepressant target in rodent models"],"prefix":"10.1016","author":[{"given":"Kelly L.","family":"McHugh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John P.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/bs.pbr.2018.07.003_bb0010","first-page":"S95","article-title":"THE CONCISE GUIDE TO PHARMACOLOGY 2017\/18: Opioid receptors","volume":"174","author":"Alexander","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0015","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1177\/0269881115586937","article-title":"Combined administration of buprenorphine and naltrexone produces antidepressant-like effects in mice","volume":"29","author":"Almatroudi","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0020","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1111\/bph.14060","article-title":"Antidepressant-like effects of BU10119, a novel buprenorphine analogue with mixed \u03ba\/\u03bc receptor antagonist properties, in mice","volume":"175","author":"Almatroudi","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0025","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s002130100793","article-title":"Withdrawal from chronic morphine administration causes prolonged enhancement of immobility in rat forced swimming test","volume":"157","author":"Anraku","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0030","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.neuropharm.2016.02.003","article-title":"Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic-versus antidepressant-like effects of nociceptin\/orphanin FQ receptor ligands","volume":"105","author":"Asth","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0035","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1037\/a0022721","article-title":"Examining the use of tramadol hydrochloride as an antidepressant","volume":"19","author":"Barber","year":"2011","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0040","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s00213-005-0167-4","article-title":"Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats","volume":"183","author":"Beardsley","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0045","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2045-5380-1-9","article-title":"Criteria of validity for animal models of psychiatric disorders: focus on anxiety disorders and depression","volume":"1","author":"Belzung","year":"2011","journal-title":"Biol. Mood Anxiety Disord."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0050","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1124\/jpet.107.120915","article-title":"In vivo effect of venlafaxine on locus coeruleus neurons: role of opioid, alpha(2)-adrenergic, and 5-hydroxytryptamine(1A) receptors","volume":"322","author":"Berrocoso","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0055","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.neulet.2004.03.041","article-title":"Non-selective opioid receptor antagonism of the antidepressant-like effect of venlafaxine in the forced swimming test in mice","volume":"363","author":"Berrocoso","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0060","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1017\/S1461145711001842","article-title":"Active behaviours produced by antidepressants and opioids in the mouse tail suspension test","volume":"16","author":"Berrocoso","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0065","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF02246283","article-title":"Effects of morphine, naloxone and their interaction in the learned-helplessness paradigm in rats","volume":"123","author":"Besson","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0070","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.psychres.2013.06.023","article-title":"Treatment inadequacy in primary and specialized care patients with depressive and\/or anxiety disorders","volume":"210","author":"Bet","year":"2013","journal-title":"Psychiatry Res."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0075","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1038\/sj.npp.1301370","article-title":"Preproenkephalin knockout mice show no depression-related phenotype","volume":"32","author":"Bilkei-Gorzo","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0080","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/j.1476-5381.2009.00230.x","article-title":"Potential anxiolytic- and antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents","volume":"157","author":"Braida","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0085","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0893-133X(01)00413-4","article-title":"Nonpeptidic \u03b4-opioid receptor agonists reduce immobility in the forced swim assay in rats","volume":"26","author":"Broom","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0090","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ejphar.2011.02.039","article-title":"Antidepressant-like effect of m-trifluoromethyl-diphenyl diselenide in the mouse forced swimming test involves opioid and serotonergic systems","volume":"658","author":"Br\u00fcning","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0095","series-title":"Buprenorphine, alone and in combination with the novel opioid receptor modulator samidorphan, displays antidepressant-like effects in two rat models","first-page":"A23","author":"Burke","year":"2015"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0100","doi-asserted-by":"crossref","first-page":"S379","DOI":"10.1016\/S0924-977X(15)30493-4","article-title":"Chronic administration of buprenorphine in combination with samidorphan produces antidepressant-like effects in rats without locomotor sensitization","volume":"25","author":"Burke","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0105","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0160-5402(78)90018-9","article-title":"A new model for the detection of antidepressant drugs: olfactory bulbectomy in the rat compared with existing methods","volume":"1","author":"Cairncross","year":"1978","journal-title":"J. Pharmacol. Methods"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0110","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.bbi.2017.08.016","article-title":"Antidepressant-like effects of 3-carboxamido seco-nalmefene (3CS-nalmefene), a novel opioid receptor modulator, in a rat IFN-\u03b1-induced depression model","volume":"67","author":"Callaghan","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0115","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/sj.bjp.0704706","article-title":"[Nphe1, Arg14, Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin\/orphanin FQ receptor","volume":"136","author":"Calo","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0120","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/da.22500","article-title":"Kappa-opioid antagonists for psychiatric disorders: from bench to clinical trials","volume":"33","author":"Carlezon","year":"2016","journal-title":"Depress. Anxiety"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0125","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1124\/jpet.105.092304","article-title":"Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats","volume":"316","author":"Carlezon","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0130","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/npp.2009.183","article-title":"Antidepressant-like effects of kappa-opioid receptor antagonists in Wistar Kyoto rats","volume":"35","author":"Carr","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0135","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1177\/0269881112464828","article-title":"In vivo and in vitro characterization of naltrindole-derived ligands at the \u03ba-opioid receptor","volume":"27","author":"Casal-Dominguez","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0140","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.neuropharm.2011.06.014","article-title":"Blockade of kappa opioid receptors attenuates the development of depressive-like behaviors induced by cocaine withdrawal in rats","volume":"62","author":"Chartoff","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0145","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1460-9568.2009.06827.x","article-title":"Mu opioid receptor modulation of somatodendritic dopamine overflow: GABAergic and glutamatergic mechanisms","volume":"30","author":"Chefer","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0150","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1124\/jpet.104.068692","article-title":"Chronic antidepressant treatment causes a selective reduction of mu-opioid receptor binding and functional coupling to G proteins in the amygdala of fawn-hooded rats","volume":"310","author":"Chen","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0155","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/1098-2396(20010301)39:3<239::AID-SYN1005>3.0.CO;2-B","article-title":"Differential effects of endomorphin-1 and -2 on amphetamine sensitization: neurochemical and behavioral aspects","volume":"39","author":"Chen","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0160","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.pharmthera.2013.06.003","article-title":"Delta opioid receptors in brain function and diseases","volume":"140","author":"Chung","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0165","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.npep.2014.07.001","article-title":"Desipramine and citalopram attenuate pretest swim-induced increases in prodynorphin immunoreactivity in the dorsal bed nucleus of the stria terminalis and the lateral division of the central nucleus of the amygdala in the forced swimming test","volume":"48","author":"Chung","year":"2014","journal-title":"Neuropeptides"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0170","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.bbr.2014.10.029","article-title":"Delta opioid receptors expressed in forebrain GABAergic neurons are responsible for SNC80-induced seizures","volume":"278","author":"Chung","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0175","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1177\/1529100617727266","article-title":"Three approaches to understanding and classifying mental disorder: ICD-11, DSM-5, and the National Institute of Mental Health's Research Domain Criteria (RDoC)","volume":"18","author":"Clark","year":"2017","journal-title":"Psychol. Sci. Public Interest"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0180","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S0022-3565(25)39544-3","article-title":"Convulsive effects of systemic administration of the delta opioid agonist BW373U86 in mice","volume":"267","author":"Comer","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0185","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1021\/acschemneuro.7b00042","article-title":"The rodent forced swim test measures stress-coping strategy, not depression-like behavior","volume":"8","author":"Commons","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0190","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.neuropharm.2011.07.021","article-title":"Effect of potent endomorphin degradation blockers on analgesic and antidepressant-like responses in mice","volume":"61","author":"Cravezic","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0195","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.neubiorev.2005.03.009","article-title":"The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice","volume":"29","author":"Cryan","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0200","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF02245592","article-title":"Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants","volume":"121","author":"Detke","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0205","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0022-3565(25)24578-5","article-title":"Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats","volume":"244","author":"Di Chiara","year":"1988","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0210","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0304-3940(99)00579-0","article-title":"Orphanin FQ reduces morphine-induced dopamine release in the nucleus accumbens: a microdialysis study in rats","volume":"272","author":"Di Giannuario","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0215","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.brainresbull.2014.03.004","article-title":"Hesperidin exerts antidepressant-like effects in acute and chronic treatments in mice: possible role of l-arginine-NO-cGMP pathway and BDNF levels","volume":"104","author":"Donato","year":"2014","journal-title":"Brain Res. Bull."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0220","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.neubiorev.2005.03.017","article-title":"Recent advances in animal models of chronic antidepressant effects: the novelty-induced hypophagia test","volume":"29","author":"Dulawa","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0225","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00213-010-1836-5","article-title":"Depressive-like effects of the kappa opioid receptor agonist salvinorin A are associated with decreased phasic dopamine release in the nucleus accumbens","volume":"210","author":"Ebner","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0230","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1038\/npp.2014.330","article-title":"Evaluation of opioid modulation in major depressive disorder","volume":"40","author":"Ehrich","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0235","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s00213-014-3723-y","article-title":"Effects of buprenorphine on behavioral tests for antidepressant and anxiolytic drugs in mice","volume":"232","author":"Falcon","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0240","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1038\/npp.2016.38","article-title":"Antidepressant-like effects of buprenorphine are mediated by kappa opioid receptors","volume":"41","author":"Falcon","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0245","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1176\/appi.ajp.2015.15070921","article-title":"Opioid modulation with buprenorphine\/samidorphan as adjunctive treatment for inadequate response to antidepressants: a randomized double-blind placebo-controlled trial","volume":"173","author":"Fava","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0250","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/sj.npp.1301149","article-title":"Antidepressant-like effect of endomorphin-1 and endomorphin-2 in mice","volume":"32","author":"Fichna","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0255","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ejphar.2012.11.003","article-title":"Kappa-opioid receptors mediate the antidepressant-like activity of hesperidin in the mouse forced swimming test","volume":"698","author":"Filho","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0260","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/76061","article-title":"Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses","volume":"25","author":"Filliol","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0265","doi-asserted-by":"crossref","first-page":"e411","DOI":"10.1038\/tp.2014.30","article-title":"The atypical antidepressant and neurorestorative agent tianeptine is a \u03bc-opioid receptor agonist","volume":"4","author":"Gassaway","year":"2014","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/bs.pbr.2018.07.003_bb9000","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00210-006-0035-8","article-title":"Antidepressant- and anxiolytic-like effects of nociceptin\/orphanin FQ receptor ligands","volume":"372","author":"Gavioli","year":"2006","journal-title":"Naunyn Schmiedebergs Arch Pharmacol."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0270","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.pharmthera.2013.05.008","article-title":"Nociceptin\/orphanin FQ receptor antagonists as innovative antidepressant drugs","volume":"140","author":"Gavioli","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0275","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1046\/j.1460-9568.2003.02603.x","article-title":"Blockade of nociceptin\/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test","volume":"17","author":"Gavioli","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0280","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00210-004-0939-0","article-title":"Antidepressant-like effects of the nociceptin\/orphanin FQ receptor antagonist UFP-101: new evidence from rats and mice","volume":"369","author":"Gavioli","year":"2004","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0285","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/hipo.20760","article-title":"Endogenous nociceptin\/orphanin-FQ in the dorsal hippocampus facilitates despair-related behavior","volume":"20","author":"Goeldner","year":"2010","journal-title":"Hippocampus"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0290","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bbr.2016.11.008","article-title":"Effects of repeated treatment with a delta opioid receptor agonist KNT-127 on hyperemotionality in olfactory-bulbectomized rats","volume":"323","author":"Gotoh","year":"2017","journal-title":"Behav. Brain Res."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0295","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1124\/jpet.111.185108","article-title":"Pharmacological characterization of 2-methyl-N-((2'-(pyrrolidin-1-ylsulfonyl)biphenyl-4-yl)methyl)propan-1-amine (PF-04455242), a high-affinity antagonist selective for \u03ba-opioid receptors","volume":"339","author":"Grimwood","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0300","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1097\/FBP.0b013e3283586189","article-title":"Antidepressive effects of the \u03ba-opioid receptor agonist salvinorin A in a rat model of anhedonia","volume":"23","author":"Harden","year":"2012","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0305","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3389\/fnmol.2018.00100","article-title":"Delta opioid receptor signaling promotes resilience to stress under the repeated social defeat paradigm in mice","volume":"11","author":"Henry","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1037\/a0038550","article-title":"A brief history of the development of antidepressant drugs: from monoamines to glutamate","volume":"23","author":"Hillhouse","year":"2015","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0315","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.neuroscience.2005.03.065","article-title":"Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens","volume":"135","author":"Hirose","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0320","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1007\/s00213-016-4310-1","article-title":"Antidepressant activity of nociceptin\/orphanin FQ receptor antagonists in the mouse learned helplessness","volume":"233","author":"Holanda","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0325","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/ilar\/ilu002","article-title":"Social defeat as an animal model for depression","volume":"55","author":"Hollis","year":"2014","journal-title":"ILAR J."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0330","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejphar.2016.03.061","article-title":"Synergistic antidepressant-like effects between a kappa opioid antagonist (LY2444296) and a delta opioid agonist (ADL5859) in the mouse forced swim test","volume":"781","author":"Huang","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0335","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1124\/jpet.111.179432","article-title":"Preclinical pharmacology of AZD2327: a highly selective agonist of the \u03b4-opioid receptor","volume":"338","author":"Hudzik","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0340","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1254\/jphs.10136SC","article-title":"Antidepressant-like effect of venlafaxine is abolished in \u03bc-opioid receptor-knockout mice","volume":"114","author":"Ide","year":"2010","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0345","first-page":"355","article-title":"Human opiorphin is a naturally occurring antidepressant acting selectively on enkephalin-dependent delta-opioid pathways","volume":"61","author":"Javelot","year":"2010","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0350","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.pbb.2010.02.011","article-title":"Evidence for the involvement of the noradrenergic system, dopaminergic and imidazoline receptors in the antidepressant-like effect of tramadol in mice","volume":"95","author":"Jesse","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0355","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1124\/jpet.103.061242","article-title":"Delta-opioid agonists: differential efficacy and potency of SNC80, its 3-OH (SNC86) and 3-desoxy (SNC162) derivatives in Sprague-Dawley rats","volume":"309","author":"Jutkiewicz","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0360","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s00213-005-0138-9","article-title":"Separation of the convulsions and antidepressant-like effects produced by the delta-opioid agonist SNC80 in rats","volume":"182","author":"Jutkiewicz","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0365","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ejphar.2005.12.002","article-title":"Behavioral and neurobiological effects of the enkephalinase inhibitor RB101 relative to its antidepressant effects","volume":"531","author":"Jutkiewicz","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0370","doi-asserted-by":"crossref","first-page":"785","DOI":"10.4088\/JCP.13m08725","article-title":"Safety, tolerability, and clinical effect of low-dose buprenorphine for treatment-resistant depression in midlife and older adults","volume":"75","author":"Karp","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0375","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.lfs.2016.08.031","article-title":"Opioid system mediated anti-nociceptive effect of agomelatine in mice","volume":"163","author":"Kasap","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0380","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034251","article-title":"Influence of sex and genetic background on anxiety-related and stress-induced behaviour of prodynorphin-deficient mice","volume":"7","author":"Kastenberger","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0385","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0091-3057(78)90051-5","article-title":"Enkephalin and other peptides reduce passiveness","volume":"9","author":"Kastin","year":"1978","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0390","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0163-7258(97)00004-1","article-title":"The olfactory bulbectomized rat as a model of depression: an update","volume":"74","author":"Kelly","year":"1997","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0395","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.brainres.2009.09.074","article-title":"Dynorphin, stress, and depression","volume":"1314C","author":"Knoll","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0400","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/fphar.2018.00093","article-title":"Sex differences in the effects of a kappa opioid receptor antagonist in the forced swim test","volume":"9","author":"Laman-Maharg","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0405","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.brainres.2013.05.005","article-title":"Acute and subchronic treatments with selective serotonin reuptake inhibitors increase nociceptin\/orphanin FQ (NOP) receptor density in the rat dorsal raphe nucleus; interactions between nociceptin\/NOP system and serotonin","volume":"1520","author":"Le Ma\u00eetre","year":"2013","journal-title":"Brain Res."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0410","first-page":"4","article-title":"Major depressive disorder and kappa opioid receptor antagonists","volume":"1","author":"Li","year":"2016","journal-title":"Transl. Perioper. Pain Med."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0415","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0893-133X(99)00100-1","article-title":"Strain differences in the behavioral effects of antidepressant drugs in the rat forced swimming test","volume":"22","author":"L\u00f3pez-Rubalcava","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0420","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2174\/1570159043359477","article-title":"Buprenorphine: a unique drug with complex pharmacology","volume":"2","author":"Lutfy","year":"2004","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0425","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.tins.2012.11.002","article-title":"Opioid receptors: distinct roles in mood disorders","volume":"36","author":"Lutz","year":"2013","journal-title":"Trends Neurosci."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0430","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1124\/jpet.102.046433","article-title":"Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats","volume":"305","author":"Mague","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0435","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1037\/rev0000033","article-title":"Learned helplessness at fifty: insights from neuroscience","volume":"123","author":"Maier","year":"2016","journal-title":"Psychol. Rev."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0440","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1248\/bpb.b14-00006","article-title":"Dynorphin A (1-13) alleviated stress-induced behavioral impairments in mice","volume":"37","author":"Mamiya","year":"2014","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0445","doi-asserted-by":"crossref","first-page":"5674","DOI":"10.1523\/JNEUROSCI.23-13-05674.2003","article-title":"Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses","volume":"23","author":"McLaughlin","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0450","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.peptides.2015.05.006","article-title":"Blockade of nociceptin\/orphanin FQ receptor signaling reverses LPS-induced depressive-like behavior in mice","volume":"72","author":"Medeiros","year":"2015","journal-title":"Peptides"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0455","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1213\/ANE.0000000000001683","article-title":"Trends in tramadol: pharmacology, metabolism, and misuse","volume":"124","author":"Miotto","year":"2017","journal-title":"Anesth. Analg."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0460","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1523\/JNEUROSCI.2442-16.2016","article-title":"Functional \u03bc-opioid-galanin receptor heteromers in the ventral tegmental area","volume":"37","author":"Moreno","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0465","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejphar.2004.03.028","article-title":"Deltorphin II enhances extracellular levels of dopamine in the nucleus accumbens via opioid receptor-independent mechanisms","volume":"491","author":"Murakawa","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0470","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1471-4159.1999.0730179.x","article-title":"Orphanin FQ\/nociceptin modulation of mesolimbic dopamine transmission determined by microdialysis","volume":"73","author":"Murphy","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0475","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0306-4522(96)00322-3","article-title":"Intracerebroventricular orphanin FQ\/nociceptin suppresses dopamine release in the nucleus accumbens of anaesthetized rats","volume":"75","author":"Murphy","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0480","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s40264-018-0660-4","article-title":"Comparative rates of mortality and serious adverse effects among commonly prescribed opioid analgesics","volume":"41","author":"Murphy","year":"2018","journal-title":"Drug Saf."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0485","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejphar.2007.03.031","article-title":"NIH 11082 produces anti-depressant-like activity in the mouse tail-suspension test through a delta-opioid receptor mechanism of action","volume":"566","author":"Naidu","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0490","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.neuroscience.2005.06.025","article-title":"Physiological control of emotion-related behaviors by endogenous enkephalins involves essentially the delta opioid receptors","volume":"135","author":"Nieto","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0495","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1517\/14728222.11.2.145","article-title":"Protection of endogenous enkephalin catabolism as natural approach to novel analgesic and antidepressant drugs","volume":"11","author":"Noble","year":"2007","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0500","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00213-007-0964-z","article-title":"Use of preproenkephalin knockout mice and selective inhibitors of enkephalinases to investigate the role of enkephalins in various behaviours","volume":"196","author":"Noble","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0505","doi-asserted-by":"crossref","first-page":"5376","DOI":"10.1111\/bph.12852","article-title":"In vivo properties of KNT-127, a novel \u03b4 opioid receptor agonist: receptor internalization, antihyperalgesia and antidepressant effects in mice","volume":"171","author":"Nozaki","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0510","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.neuropharm.2005.04.014","article-title":"Time course of opioid and cannabinoid gene transcription alterations induced by repeated administration with fluoxetine in the rat brain","volume":"49","author":"Oliva","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0515","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1124\/jpet.109.159939","article-title":"Direct agonist activity of tricyclic antidepressants at distinct opioid receptor subtypes","volume":"332","author":"Onali","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0520","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0006-8993(10)80029-0","article-title":"Activation of kappa-opioid receptors depresses electrically evoked excitatory postsynaptic potentials on 5-HT-sensitive neurones in the rat dorsal raph\u00e9 nucleus in vitro","volume":"583","author":"Pinnock","year":"1992","journal-title":"Brain Res."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0525","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/266730a0","article-title":"Depression: a new animal model sensitive to antidepressant treatment","volume":"266","author":"Porsolt","year":"1977","journal-title":"Nature"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0530","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1038\/npp.2015.348","article-title":"A selective nociceptin receptor antagonist to treat depression: evidence from preclinical and clinical studies","volume":"41","author":"Post","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0535","first-page":"1","article-title":"Pharmacodynamic and pharmacokinetic evaluation of buprenorphine+samidorphan for the treatment of major depressive disorder","volume":"6","author":"Ragguett","year":"2018","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0540","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s00210-001-0511-0","article-title":"Nociceptin receptor antagonists display antidepressant-like properties in the mouse forced swimming test","volume":"365","author":"Redrobe","year":"2002","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0545","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/npp.2017.205","article-title":"Repeated administration of opra kappa (LY2456302), a novel, short-acting, selective KOP-r antagonist, in persons with and without cocaine dependence","volume":"43","author":"Reed","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0550","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s00213-015-4195-4","article-title":"A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression","volume":"233","author":"Richards","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0555","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1124\/jpet.106.116780","article-title":"Pharmacological characterization of the nociceptin\/orphanin FQ receptor antagonist SB-612111 [(\u2212)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vivo studies","volume":"321","author":"Rizzi","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0560","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.neuropharm.2010.12.010","article-title":"Nociceptin\/orphanin FQ receptor knockout rats: in vitro and in vivo studies","volume":"60","author":"Rizzi","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0565","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bbr.2016.10.050","article-title":"A role for the mu opioid receptor in the antidepressant effects of buprenorphine","volume":"319","author":"Robinson","year":"2017","journal-title":"Behav. Brain Res."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0570","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.2174\/13816128113196660741","article-title":"Genetically modified mice as tools to understand the neurobiological substrates of depression","volume":"20","author":"Robledo","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0575","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0024-3205(02)02220-8","article-title":"Antidepressant-like effects of tramadol and other central analgesics with activity on monoamines reuptake, in helpless rats","volume":"72","author":"Rojas-Corrales","year":"2002","journal-title":"Life Sci."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0580","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1177\/026988110401800305","article-title":"Antidepressant-like effect of tramadol and its enantiomers in reserpinized mice: comparative study with desipramine, fluvoxamine, venlafaxine and opiates","volume":"18","author":"Rojas-Corrales","year":"2004","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0585","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neuropharm.2013.09.021","article-title":"LY2456302 is a novel, potent, orally-bioavailable small molecule kappa-selective antagonist with activity in animal models predictive of efficacy in mood and addictive disorders","volume":"77","author":"Rorick-Kehn","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0590","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1177\/0269881117724353","article-title":"Opioid system contribution to the antidepressant-like action of m-trifluoromethyl-diphenyl diselenide in mice: a compound devoid of tolerance and withdrawal syndrome","volume":"31","author":"Rosa","year":"2017","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0595","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-018-1024-x","article-title":"m-Trifluoromethyl-diphenyl diselenide regulates prefrontal cortical MOR and KOR protein levels and abolishes the phenotype induced by repeated forced swim stress in mice","author":"Rosa","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0600","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.biopsych.2013.07.042","article-title":"Sex differences in sensitivity to the depressive-like effects of the kappa opioid receptor agonist U-50488 in rats","volume":"76","author":"Russell","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0605","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1038\/sj.npp.1300514","article-title":"Hippocampal brain-derived neurotrophic factor expression following treatment with reboxetine, citalopram, and physical exercise","volume":"29","author":"Russo-Neustadt","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0610","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2174\/157015912803217314","article-title":"Antidepressant-like effects of \u03b4 opioid receptor agonists in animal models","volume":"10","author":"Saitoh","year":"2012","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0615","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1254\/jphs.FPJ04014X","article-title":"Potential anxiolytic and antidepressant-like activities of SNC80, a selective delta-opioid agonist, in behavioral models in rodents","volume":"95","author":"Saitoh","year":"2004","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0620","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.brainres.2007.07.095","article-title":"Antidepressant-like effects of the delta-opioid receptor agonist SNC80 ([(+)-4-[(alphaR)-alpha-[(2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide) in an olfactory bulbectomized rat model","volume":"1208","author":"Saitoh","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0625","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.bbr.2011.04.041","article-title":"The novel \u03b4 opioid receptor agonist KNT-127 produces antidepressant-like and antinociceptive effects in mice without producing convulsions","volume":"223","author":"Saitoh","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0630","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1038\/npp.2017.60","article-title":"The behavioral effects of the antidepressant tianeptine require the mu-opioid receptor","volume":"42","author":"Samuels","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0635","doi-asserted-by":"crossref","first-page":"17582","DOI":"10.1523\/JNEUROSCI.3220-12.2012","article-title":"Stress produces aversion and potentiates cocaine reward by releasing endogenous dynorphins in the ventral striatum to locally stimulate serotonin reuptake","volume":"32","author":"Schindler","year":"2012","journal-title":"J. Neurosci."},{"issue":"21","key":"10.1016\/bs.pbr.2018.07.003_bb0640","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0196-9781(00)00233-3","article-title":"Nociceptin\/orphanin FQ and neurotransmitter release in the central nervous system","volume":"2000","author":"Schlicker","year":"2000","journal-title":"Peptides"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0645","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1385\/JMN:18:1-2:143","article-title":"Venlafaxine and mirtazapine different mechanisms of antidepressant action, common opioid-mediated antinociceptive effects\u2014a possible opioid involvement in severe depression?","volume":"18","author":"Schreiber","year":"2002","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0650","first-page":"542","article-title":"Learned helplessness in the rat: time course, immunization, and reversibility","volume":"88","author":"Seligman","year":"1975","journal-title":"J. Comp. Physiol."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0655","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9724371","article-title":"The link between depression and chronic pain: neural mechanisms in the brain","volume":"2017","author":"Sheng","year":"2017","journal-title":"Neural Plast."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0660","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/j.1471-4159.2004.02589.x","article-title":"Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant-like effects","volume":"90","author":"Shirayama","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0665","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1111\/j.1471-4159.1990.tb04963.x","article-title":"The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study","volume":"55","author":"Spanagel","year":"1990","journal-title":"J. Neurochem."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0670","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1073\/pnas.89.6.2046","article-title":"Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway","volume":"89","author":"Spanagel","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0675","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0680","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1124\/jpet.102.037861","article-title":"Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system","volume":"303","author":"Tao","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0685","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.neuroscience.2007.02.011","article-title":"Nociceptin\/orphanin FQ decreases serotonin efflux in the rat brain but in contrast to a kappa-opioid has no antagonistic effect on mu-opioid-induced increases in serotonin efflux","volume":"147","author":"Tao","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0690","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2174\/1570159X13666150727220944","article-title":"Kappa opioids, salvinorin A and major depressive disorder","volume":"14","author":"Taylor","year":"2016","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0695","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0091-3057(95)00067-7","article-title":"Implication of endogenous opioid system in the learned helplessness model of depression","volume":"52","author":"Tejedor-Real","year":"1995","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0700","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(98)00423-3","article-title":"Involvement of delta-opioid receptors in the effects induced by endogenous enkephalins on learned helplessness model","volume":"354","author":"Tejedor-Real","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0705","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/10550880802122646","article-title":"Psychotherapeutic benefits of opioid agonist therapy","volume":"27","author":"Tenore","year":"2008","journal-title":"J. Addict. Dis."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0710","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejphar.2008.03.020","article-title":"(+)-Morphine attenuates the (\u2212)-morphine-produced conditioned place preference and the mu-opioid receptor-mediated dopamine increase in the posterior nucleus accumbens of the rat","volume":"587","author":"Terashvili","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0715","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00213-003-1680-y","article-title":"Effects of kappa-opioid receptor ligands on intracranial self-stimulation in rats","volume":"172","author":"Todtenkopf","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0720","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1124\/pr.114.009209","article-title":"Nociceptin\/orphanin FQ receptor structure, signaling, ligands, functions, and interactions with opioid systems","volume":"68","author":"Toll","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0725","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00213-005-0113-5","article-title":"Chronic administration of the delta opioid receptor agonist (+)BW373U86 and antidepressants on behavior in the forced swim test and BDNF mRNA expression in rats","volume":"183","author":"Torregrossa","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0730","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.brainres.2005.11.005","article-title":"Peptidic delta opioid receptor agonists produce antidepressant-like effects in the forced swim test and regulate BDNF mRNA expression in rats","volume":"1069","author":"Torregrossa","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0735","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1007\/s00702-002-0764-x","article-title":"Effects of U-50,488H, a kappa-opioid receptor agonist, on the learned helplessness model of depression in mice","volume":"109","author":"Ukai","year":"2002","journal-title":"J. Neural. Transm."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0740","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1007\/s00213-017-4647-0","article-title":"Effects of the novel relatively short-acting kappa opioid receptor antagonist LY2444296 in behaviors observed after chronic extended-access cocaine self-administration in rats","volume":"234","author":"Valenza","year":"2017","journal-title":"Psychopharmacology"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0745","first-page":"21","article-title":"Effects of imipramine treatment on delta-opioid receptors of the rat brain cortex and striatum","volume":"53","author":"Varona","year":"2003","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0750","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1016\/j.peptides.2006.07.015","article-title":"Dmt-Tic-NH-CH2-Bid (UFP-502), a potent DOP receptor agonist: in vitro and in vivo studies","volume":"27","author":"Vergura","year":"2006","journal-title":"Peptides"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0755","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.peptides.2007.10.012","article-title":"Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist","volume":"29","author":"Vergura","year":"2008","journal-title":"Peptides"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0760","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00213-009-1646-9","article-title":"Chronic treatment with the selective NOP receptor antagonist [Nphe 1, Arg 14, Lys 15]N\/OFQ-NH 2 (UFP-101) reverses the behavioural and biochemical effects of unpredictable chronic mild stress in rats","volume":"207","author":"Vitale","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0765","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1007\/s00213-016-4292-z","article-title":"The anxiolytic- and antidepressant-like effects of ATPM-ET, a novel \u03ba agonist and \u03bc partial agonist, in mice","volume":"233","author":"Wang","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0770","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00427414","article-title":"The validity of animal models of depression","volume":"83","author":"Willner","year":"1984","journal-title":"Psychopharmacology"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0775","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ynstr.2016.08.002","article-title":"The chronic mild stress (CMS) model of depression: history, evaluation and usage","volume":"6","author":"Willner","year":"2016","journal-title":"Neurobiol. Stress"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0780","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/BF00187257","article-title":"Reduction of sucrose preference by chronic mild stress and its restoration by a tricyclic antidepressant","volume":"93","author":"Willner","year":"1987","journal-title":"Psychopharmacology"},{"issue":"27","key":"10.1016\/bs.pbr.2018.07.003_bb0785","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ceb.2013.10.008","article-title":"Recent developments in biased agonism","volume":"2014","author":"Wisler","year":"2014","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0790","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.275","article-title":"Preclinical findings predicting efficacy and side-effect profile of LY2940094, an antagonist of nociceptin receptors","volume":"4","author":"Witkin","year":"2016","journal-title":"Pharmacol. Res. Perspect."},{"issue":"34","key":"10.1016\/bs.pbr.2018.07.003_bb0795","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/npp.2008.142","article-title":"Prodynorphin-derived peptides are critical modulators of anxiety and regulate neurochemistry and corticosterone","volume":"2009","author":"Wittmann","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0800","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neulet.2010.12.002","article-title":"The antidepressant-like effect of human opiorphin via opioid-dependent pathways in mice","volume":"489","author":"Yang","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0805","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.brainres.2016.09.027","article-title":"Stress-based animal models of depression: do we actually know what we are doing?","volume":"1652","author":"Yin","year":"2016","journal-title":"Brain Res."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0810","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/386499a0","article-title":"A potent and selective endogenous agonist for the \u03bc-opiate receptor","volume":"386","author":"Zadina","year":"1997","journal-title":"Nature"},{"key":"10.1016\/bs.pbr.2018.07.003_bb0815","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.bbr.2015.05.053","article-title":"Antagonism of \u03ba opioid receptor in the nucleus accumbens prevents the depressive-like behaviors following prolonged morphine abstinence","volume":"291","author":"Zan","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0820","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/j.1460-9568.2006.04621.x","article-title":"Endogenous opioids upregulate brain-derived neurotrophic factor mRNA through delta- and micro-opioid receptors independent of antidepressant-like effects","volume":"23","author":"Zhang","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0825","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejphar.2007.05.045","article-title":"Central kappa-opioid receptor-mediated antidepressant-like effects of nor-binaltorphimine: behavioral and BDNF mRNA expression studies","volume":"570","author":"Zhang","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0830","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.neulet.2005.02.026","article-title":"Evidence for the involvement of the opioid system in the agmatine antidepressant-like effect in the forced swimming test","volume":"381","author":"Zomkowski","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0835","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1017\/S1461145709000236","article-title":"Cooperative opioid and serotonergic mechanisms generate superior antidepressant-like effects in a mice model of depression","volume":"12","author":"Berrocoso","year":"2009","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/bs.pbr.2018.07.003_bb0840","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/j.1476-5381.2012.02078.x","article-title":"The atypical antidepressant mianserin exhibits agonist activity at \u03ba-opioid receptors","volume":"167","author":"Olianas","year":"2012","journal-title":"Br. J. Pharmacol."}],"container-title":["Progress in Brain Research","The Opioid System as the Interface between the Brain\u2019s Cognitive and Motivational Systems"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0079612318300645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0079612318300645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T10:29:31Z","timestamp":1751884171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0079612318300645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9780444641670"],"references-count":168,"URL":"https:\/\/doi.org\/10.1016\/bs.pbr.2018.07.003","relation":{},"ISSN":["0079-6123"],"issn-type":[{"value":"0079-6123","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}